This inventor holds 1 USPTO granted patent. Top assignee: Bausch Health Ireland Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jacob Cole and Targeted Rifaximin Delivery
Introduction
Jacob Cole is an inventor associated with Fairport, New York. His patent work concerns targeted delivery of rifaximin to specific portions of the gastrointestinal tract.
Latest Patents
Cole is named on 1 patent: “Targeted Release Rifaximin Compositions.” The patent describes gastrointestinal-specific rifaximin compositions designed to deliver the medication to one or more parts of the GI tract. It also addresses methods for treating diseases and disorders using these compositions.
Career Highlights
Cole is associated with Bausch Health Ireland Limited. His listed patent reflects work on pharmaceutical formulations and targeted drug delivery.
Collaborations
Cole’s listed coworkers include Brian R. Rohrs and Daniel J. Stein.
Conclusion
Jacob Cole’s patent activity centers on targeted rifaximin compositions intended to support treatment by delivering the medication to selected areas of the gastrointestinal tract.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile